BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 26425687)

  • 1. Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.
    Ventura R; Mordec K; Waszczuk J; Wang Z; Lai J; Fridlib M; Buckley D; Kemble G; Heuer TS
    EBioMedicine; 2015 Aug; 2(8):808-24. PubMed ID: 26425687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and Gene Expression.
    Heuer TS; Ventura R; Mordec K; Lai J; Fridlib M; Buckley D; Kemble G
    EBioMedicine; 2017 Feb; 16():51-62. PubMed ID: 28159572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts.
    Santolla MF; Lappano R; De Marco P; Pupo M; Vivacqua A; Sisci D; Abonante S; Iacopetta D; Cappello AR; Dolce V; Maggiolini M
    J Biol Chem; 2012 Dec; 287(52):43234-45. PubMed ID: 23135268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FASN inhibition as a potential treatment for endocrine-resistant breast cancer.
    Gruslova A; McClellan B; Balinda HU; Viswanadhapalli S; Alers V; Sareddy GR; Huang T; Garcia M; deGraffenried L; Vadlamudi RK; Brenner AJ
    Breast Cancer Res Treat; 2021 Jun; 187(2):375-386. PubMed ID: 33893909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
    Zadra G; Ribeiro CF; Chetta P; Ho Y; Cacciatore S; Gao X; Syamala S; Bango C; Photopoulos C; Huang Y; Tyekucheva S; Bastos DC; Tchaicha J; Lawney B; Uo T; D'Anello L; Csibi A; Kalekar R; Larimer B; Ellis L; Butler LM; Morrissey C; McGovern K; Palombella VJ; Kutok JL; Mahmood U; Bosari S; Adams J; Peluso S; Dehm SM; Plymate SR; Loda M
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):631-640. PubMed ID: 30578319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration.
    Zaytseva YY; Harris JW; Mitov MI; Kim JT; Butterfield DA; Lee EY; Weiss HL; Gao T; Evers BM
    Oncotarget; 2015 Aug; 6(22):18891-904. PubMed ID: 25970773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
    Zaytseva YY; Rychahou PG; Le AT; Scott TL; Flight RM; Kim JT; Harris J; Liu J; Wang C; Morris AJ; Sivakumaran TA; Fan T; Moseley H; Gao T; Lee EY; Weiss HL; Heuer TS; Kemble G; Evers M
    Oncotarget; 2018 May; 9(37):24787-24800. PubMed ID: 29872506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib.
    Li CF; Fang FM; Chen YY; Liu TT; Chan TC; Yu SC; Chen LT; Huang HY
    Clin Cancer Res; 2017 Aug; 23(16):4908-4918. PubMed ID: 28442505
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
    Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
    Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular fatty acid synthase is required for late stages of HIV-1 replication.
    Kulkarni MM; Ratcliff AN; Bhat M; Alwarawrah Y; Hughes P; Arcos J; Loiselle D; Torrelles JB; Funderburg NT; Haystead TA; Kwiek JJ
    Retrovirology; 2017 Sep; 14(1):45. PubMed ID: 28962653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatilla saponin E suppresses viability, migration, invasion and promotes apoptosis of NSCLC cells through negatively regulating Akt/FASN pathway
    Zhu M; Shi W; Chen K; Hu H; Ye X; Jiang Y
    J Recept Signal Transduct Res; 2022 Feb; 42(1):23-33. PubMed ID: 33243063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
    Zhang W; Huang J; Tang Y; Yang Y; Hu H
    Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
    Huang LH; Chung HY; Su HM
    BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
    Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian fatty acid synthase activity from crude tissue lysates tracing ¹³C-labeled substrates using gas chromatography-mass spectrometry.
    Rudolph MC; Karl Maluf N; Wellberg EA; Johnson CA; Murphy RC; Anderson SM
    Anal Biochem; 2012 Sep; 428(2):158-66. PubMed ID: 22728958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
    Di Vizio D; Adam RM; Kim J; Kim R; Sotgia F; Williams T; Demichelis F; Solomon KR; Loda M; Rubin MA; Lisanti MP; Freeman MR
    Cell Cycle; 2008 Jul; 7(14):2257-67. PubMed ID: 18635971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth.
    Drury J; Geisen ME; Tessmann JW; Rychahou PG; Kelson CO; He D; Wang C; Evers BM; Zaytseva YY
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
    Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
    Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.